new/era/mabs
Potsdam, Germany neweramabs.com From their website, Nov 2026
Work here? Claim this listing
About
new/era/mabs develops antibody discovery, screening, assay, and manufacturing solutions for research, diagnostics, and therapeutic development. It works with mouse, human, and camelid antibody sources and offers customized support from target analysis to delivery. The company is based in Germany and was founded as a university spin-off in 2014.
Services
Customized antibody sets
Provides small-scale sets of target-specific antibodies from camelid, mouse, and human origins.
Antigen-specific immortal cell pools
Creates reusable target-specific cell pools for iterative and infinite screening against desired antigens.
End-to-end antibody discovery support
Supports the workflow from target analysis through screening and purification.
Antibody modification
Modifies selected antibodies with tags, fluorescence, enzyme labeling, biotinylation, and different formats.
Protein production
Assay development
Develops customized antibody-based assay formats and flow cytometry workflows.
Recombinant protein expression
Uses in-house recombinant protein expression systems to create target variations.
Protein production
Antibody and recombinant protein manufacturing
Provides antibody and recombinant protein manufacturing at small and large scale.
Protein production
Overexpressing cell line generation
Generates overexpressing cell lines.
4 more services
- End-to-End Support
- Versatile Modifications
- Specialized Assay Development
- AI-based in silico epitope modeling
- Turnaround
- 4 times faster than conventional methods
Capabilities
- Assays and studies
- Antibodies
- Rodent models
- Flow cytometry
- Bispecifics
- Indirect immunoassays
- Direct immunoassays
7 more
- Competitive immunoassays
- Flow cytometry multi-staining panels
- Immunofluorescence
- Bead-based purifications
- Pull-down assays
- Flow cytometric multi-staining
- Flow cytometry workflows
- Scale and capacity
- Small-scale sets
- Small and large-scale options
- Small and large-scale antibody and recombinant protein manufacturing
- Therapeutic areas
- Diagnostics
- Therapeutics
- Personalized health care
- Pandemic preparedness
- Neurodegenerative targets
- Malaria
3 more
- Influenza
- Therapy
- Neurodegenerative disease
Instruments and platforms
- Flow cytometry
Modalities and species
- Modalities
- Antibody
- Bispecific
- Recombinant protein
- Species and models
- Mouse
- Human
- Camelid
- Camelid VHH
- Mouse monoclonal antibodies
- Human monoclonal antibodies
Industries served
- Diagnostics
- Therapeutics
- Research
Details
- Founded
- 2014
- Quality
- Certified management process
- Based in
- Potsdam, Germany
- General enquiry
- contact@neweramabs.com on their site